Recombinant adeno-associated virus (rAAV) is a leading viral vector modality for gene therapy, with several approved treatments and hundreds of ongoing clinical trials. rAAV manufacturing, while ...
This proposal aims to develop an integrated, scalable, high-throughput recombinant adeno-associated virus (rAAV) screening and optimization platform to address the challenges associated with vector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results